Search results
May 17, 2024 · Analyst Forecast. According to 9 analysts, the average rating for IMRX stock is "Buy." The 12-month stock price forecast is $15.14, which is an increase of 929.93% from the latest price. Price Target. $15.14.
NASDAQ does not use this value to determine compliance with the listing requirements. Immuneering Corporation Class A Common Stock (IMRX) Stock Quotes - Nasdaq offers stock quotes & market ...
2 days ago · IMAX Corporation Reports First Quarter 2024 Earnings Results. Global entertainment platform delivers Revenue of $79 million and strong profitability, including Net Income of $3.3 million up 33% YoY and Total Adjusted EBITDA Margin (1) of 40.5% up more than 300 ba... 27 days ago - PRNewsWire.
A high-level overview of Immuneering Corporation (IMRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
IMRX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View Immuneering Corp. Class A IMRX stock quote prices, financial information, real-time forecasts, and company news from CNN.
May 17, 2024 · Their IMRX share price targets range from $3.00 to $25.00. On average, they expect the company's stock price to reach $13.50 in the next twelve months. This suggests a possible upside of 850.7% from the stock's current price. View analysts price targets for IMRX or view top-rated stocks among Wall Street analysts.
IMRX stock has fallen by 7.55% compared to the previous week, the month change is a 21.39% fall, over the last year Immuneering Corporation has showed a 82.73% decrease.
